COMPASS Pathways (CMPS) reported Wednesday that its Q1 loss widened to $0.30 per diluted share from a loss of $0.24 a year earlier.
Analysts polled by FactSet expected a loss of $0.43.
The company reported no revenue for the quarter ended March 31.
As of March 31, the mental health care firm said it had $466 million in cash and or cash equivalents, compared with $149.6 million a year earlier, sufficient to fund operating expenses and capital expenditure requirements into 2028.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.